Edgeworth Economics’ Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog
Edgeworth Economics today debuts The Antitrust Prescription, the firm’s new blog that covers antitrust and other economic issues affecting companies in the pharmaceutical industry.
- Edgeworth Economics today debuts The Antitrust Prescription, the firm’s new blog that covers antitrust and other economic issues affecting companies in the pharmaceutical industry.
- The blog is an industry resource provided by Edgeworth’s Pharmaceutical Economics practice, which is dedicated to assisting companies and legal counsel with the most pressing economic issues in the space.
- Edgeworth Economics has deep experience analyzing economic and econometric issues in the pharmaceutical industry in the areas of antitrust, intellectual property, commercial damages, and consumer protection.
- Our pharmaceutical economics experts have assisted clients across the industry, including brand and generic pharmaceutical companies, biotechnology companies, product manufacturers, healthcare providers, and insurers.